BioRestorative Therapies ...

NASDAQ: BRTX · Real-Time Price · USD
1.51
0.01 (0.65%)
At close: Aug 15, 2025, 3:50 PM
1.52
0.66%
After-hours: Aug 15, 2025, 04:00 PM EDT

BioRestorative Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-8.98M -10.42M -18.49M -44.3M
Depreciation & Amortization
189.06K 165.74K 120.55K 89.11K
Stock-Based Compensation
2.81M 7.78M 12.61M 23.11M
Other Working Capital
-95.93K 500.14K -94.93K 380.71K
Other Non-Cash Items
-2.28M -4.48M -123.54K 1.27M
Deferred Income Tax
n/a n/a n/a 16.18M
Change in Working Capital
28.65K 515.33K 14.14K 324.69K
Operating Cash Flow
-8.23M -6.43M -5.87M -3.33M
Capital Expenditures
-106.19K -171.04K -440.22K -30.66K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-20.89M -17.54M -22.45M n/a
Sales Maturities Of Investments
21.51M 20.96M 9.49M n/a
Other Investing Acitivies
n/a n/a -79.53K n/a
Investing Cash Flow
514.53K 3.25M -13.48M -30.66K
Debt Repayment
n/a n/a n/a 250K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-623.8K n/a n/a n/a
Other Financial Acitivies
475.1K n/a n/a n/a
Financial Cash Flow
7.38M 2.35M n/a 21.32M
Net Cash Flow
-336.49K -829.39K -19.35M 17.96M
Free Cash Flow
-8.34M -6.6M -6.31M -3.36M